Laurus Labs Ltd
NSE:LAURUSLABS

Watchlist Manager
Laurus Labs Ltd Logo
Laurus Labs Ltd
NSE:LAURUSLABS
Watchlist
Price: 486 INR 1.96%
Market Cap: 262B INR
Have any thoughts about
Laurus Labs Ltd?
Write Note

Laurus Labs Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Laurus Labs Ltd
Cash Equivalents Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Laurus Labs Ltd
NSE:LAURUSLABS
Cash Equivalents
â‚ą27.1m
CAGR 3-Years
-62%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash Equivalents
â‚ą7.1B
CAGR 3-Years
-22%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash Equivalents
â‚ą9.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
16%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash Equivalents
â‚ą90.2B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash Equivalents
â‚ą11.5B
CAGR 3-Years
49%
CAGR 5-Years
14%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Cash Equivalents
â‚ą1.2B
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Laurus Labs Ltd's Cash Equivalents?
Cash Equivalents
27.1m INR

Based on the financial report for Jun 30, 2024, Laurus Labs Ltd's Cash Equivalents amounts to 27.1m INR.

What is Laurus Labs Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-2%

Over the last year, the Cash Equivalents growth was -3%. The average annual Cash Equivalents growth rates for Laurus Labs Ltd have been -62% over the past three years , -2% over the past five years .

Back to Top